By Byron Raal, CAS Founder-Editor · Last updated 10 May 2026 · About the author
Introduction
Compressed air in pharmaceutical manufacturing is not a commodity utility: it is a critical process input whose quality directly impacts product safety, batch viability, and regulatory standing. The Therapeutic Goods Administration (TGA) and the Pharmaceutical Inspection Convention/Scheme (PIC/S) classify compressed air used in drug manufacture as either a direct contact substance (in inhalation products, for example) or an indirect support medium (powdering tablets, operating automation). In either case, contamination failures (particle, oil, or moisture ingress) trigger batch rejection, product recalls, and potential regulatory enforcement action.
This guide is written for plant managers, quality assurance leads, process engineers, and facility planners tasked with specifying, validating, or troubleshooting pharmaceutical-grade compressed air systems in Australia. Our focus is infrastructure, regulatory compliance, and system design. CAS is an independent information resource that connects enquiries to qualified suppliers; we do not provide engineering consultation. The framework and standards references below equip you to brief your equipment supplier, validate your system, and maintain compliance throughout production.
Who Should Read This
- Plant managers and pharmaceutical facility operators
- Quality assurance and regulatory compliance teams
- Process and facilities engineers specifying or validating systems
- Equipment suppliers designing systems for Australian manufacturers
- Maintenance technicians responsible for system upkeep
Regulatory Framework: TGA, PIC/S and GMP Compliance
Australia’s Therapeutic Goods Administration enforces Good Manufacturing Practice (GMP) standards for all pharmaceutical manufacturing under the Therapeutic Goods Act 1989. Compressed air is explicitly mentioned in TGA GMP Guidance documents as a critical utility requiring validation, control, and monitoring. The TGA aligns its GMP standards with the PIC/S guide, which means compliance with one framework largely satisfies the other.
Key regulatory points:
- Annex 1 (2023 revision): The latest revision includes enhanced requirements for contamination control and environmental monitoring. Compressed air systems must be designed to maintain specified air quality classes even during normal operational variations and maintenance activities.
- ISO 8573-1 air purity: Pharmaceutical compressed air is validated against ISO 8573-1:2010 Class 1.2.1 or tighter under the site’s PIC/S PE009-17 (published 25 August 2023) GMP validation protocol; TGA does not prescribe air-quality classes directly (point-of-use achieved-purity is determined by PIC/S Annex 1 Cl 6.18 quality requirements — chemical, particulate, microbial — for the contact zone, not by product category alone; aseptic, parenteral, and inhalation processing typically demands the most stringent quality classes; verification per ISO 8573-2 + Part 5 combined for total oil, Part 3 for water vapour humidity, Part 4 for solid particle count, Part 7 for viable microbiological).
- System validation: Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) are mandatory. Suppliers must provide documented evidence of design, testing, and performance.
- Ongoing monitoring: In-use monitoring (pressure, dew point, filter differential pressure) must be continuous or at defined intervals (typically daily). Records must be retained for the life of the product batch plus retention period (often 25+ years for pharmaceuticals).
- Change management: Any modification to the compressed air system (new compressor, filter upgrade, dryer change, regulator adjustment) requires change control documentation and often re-validation testing.
Air Quality Standards and ISO 8573-1 Classifications
ISO 8573-1:2010 Part 1 defines air purity in three independent dimensions: solid particle count, water content (dew point), and oil vapour concentration. Each dimension is rated on its own scale (Class 0 to 6, with 0 being the most stringent).
| ISO 8573-1 Class | Particles (μm) | Typical Pharmaceutical Use | Dew Point | Oil Content |
|---|---|---|---|---|
| Class 0 | User-defined (stricter than Class 1) | Inhalation products, parenteral drug container wash, aseptic processing where Class 1 is insufficient | User-defined (typically ≤-70°C or stricter) | User-defined (typically ≤0.01 mg/m³ or stricter) |
| Class 1 | 0.1 μm < d ≤ 0.5 μm: ≤20,000/m³; 0.5 μm < d ≤ 1.0 μm: ≤400/m³; 1.0 μm < d ≤ 5.0 μm: ≤10/m³ | Parenteral fills, closed-system transfer, aseptic processing | ≤-70°C | ≤0.01 mg/m³ |
| Class 2 | 0.1 μm < d ≤ 0.5 μm: ≤400,000/m³; 0.5 μm < d ≤ 1.0 μm: ≤6,000/m³; 1.0 μm < d ≤ 5.0 μm: ≤100/m³ | General powder manufacturing, tablet operations, encapsulation | ≤-40°C | ≤0.1 mg/m³ |
| Class 3 | 0.5 μm < d ≤ 1.0 μm: ≤90,000/m³; 1.0 μm < d ≤ 5.0 μm: ≤1,000/m³ | Non-critical operations, general facility air | ≤-20°C | ≤0.5 mg/m³ |
ISO 8573-1:2010 defines Class 0 as user-defined: stricter than Class 1, with exact particle, water and oil limits agreed between user and supplier and documented in the site quality specification. CAS does not propose universal numeric thresholds for Class 0 because the standard explicitly leaves them to site quality risk assessment.
TGA guidance does not mandate a specific class universally. The required ISO 8573-1 class is determined by the achieved purity at point-of-use against PIC/S Annex 1 Clause 6.18 quality requirements (chemical, particulate, microbial) for the contact zone, not by product category alone. Aseptic, parenteral, and inhalation processing typically demands the most stringent quality classes (Class 1 or stricter). Operations not involving direct product contact — utility air for tablet machinery actuation, packaging-line pneumatic cylinders, instrument air — may justify a less stringent class against the contact-zone risk assessment. Verification across all class axes follows the ISO 8573 series test methods: Part 4 for solid particle count, Part 3 for water vapour humidity, Part 2 + Part 5 combined for total oil, Part 7 for viable microbiological CFU.
System Design for Pharmaceutical Compressed Air
Compressor Selection and Oil-Free Requirements
PIC/S PE 009-17 Annex 1 Clause 6.18 regulates the achieved gas quality — chemical, particulate, and microbial — including oil and water content, taking into account the use and type of the gas and the design of the gas generation system. PIC/S does not prescribe a specific compressor lubrication architecture by name. Oil-free compressor technology is the most direct path to PIC/S-compliant air for direct-contact applications. Oil-injected (oil-lubricated) systems with adequate coalescing filtration and activated carbon can also achieve PIC/S-compliant utility air for non-direct-contact uses if the achieved oil content is verified per ISO 8573-2 (aerosol) and ISO 8573-5:2025 (vapour). The decision turns on the achieved purity classification at point-of-use and the application’s contact zone, not on compressor lubrication architecture alone.
Oil-free screw compressors are the standard. They are more expensive (20 to 40 per cent premium) but eliminate the oil source entirely, providing absolute certainty of air purity. Some manufacturers offer screw units with water cooling, which improves thermal efficiency and reduces the drying burden downstream.
Aftercooler, Dryer, and Multi-Stage Filtration
Pharmaceutical compressed air systems require a treatment train:
- Aftercooler: Reduces discharge temperature from the compressor (typically 80 to 120°C down to 35 to 45°C), condensing bulk moisture. Essential for effective downstream drying.
- Coarse filter (Stage 1): Removes particles ≥10 μm. Protects the dryer and downstream equipment from rapid fouling.
- Refrigerated or desiccant dryer: reduces dew point to specification. Refrigerated dryers achieve Class 4 (+3°C pressure dew point) at most; their refrigeration cycle cannot operate below approximately +3°C without freezing condensate and blocking the heat exchanger. Desiccant dryers reach Class 2 (≤-40°C PDP) and Class 1 (≤-70°C PDP). For Class 0 the site validates a custom specification stricter than Class 1. Many pharmaceutical plants run refrigerated as the primary bulk-water removal stage with desiccant downstream as the polishing stage that delivers the final dew point.
- Fine particulate filter (Stage 2): Removes particles ≥1 μm (ISO 8573-1:2010 Class 2) or ≥0.5 μm (Class 1). Often a coalescing filter that also removes residual oil aerosol.
- Ultra-fine particulate filter (Stage 3, if Class 0 or 1): Removes particles ≥0.1 μm. Necessary for strict purity. Media: borosilicate glass or PTFE, with high pressure drop and frequent change intervals.
- Activated carbon filter (if needed): Removes residual volatile organic compounds and odours. Optional for Class 2 or 3; mandatory for Class 0 or 1.
A typical Class 2 system: Oil-free compressor → Aftercooler → Coarse filter → Refrigerated dryer (bulk water removal) → Desiccant dryer (Class 2 polishing) → Fine filter → Receiver → Piping with point-of-use fine filter.
A typical Class 1 system: Oil-free compressor → Aftercooler → Coarse filter → Refrigerated dryer → Fine filter → Desiccant polishing dryer → Activated carbon filter → Receiver → Piping with point-of-use ultra-fine filter.
Receiver Sizing and Condensate Management
A properly sized receiver tank serves three functions: (1) storage to buffer demand spikes and reduce compressor unload cycles, (2) cooling to precipitate residual moisture, (3) surge volume for system stabilization.
Pharmaceutical systems size receivers from the compressor free air delivery (FAD), not motor kW alone. Per the CAS receiver-sizing guideline (receiver volume in litres ≈ FAD in L/s × 10 to 15 seconds of dwell), a 15 kW oil-free rotary screw compressor delivering approximately 30 to 40 L/s (1,800 to 2,400 L/min FAD at 7 bar) sits at roughly 300 to 600 L. See the Air Receiver Tanks Australia guide for the full method.
Condensate drainage is critical. Receivers accumulate moisture despite drying; this water must be removed daily (or via automatic float traps). Oil-water separation (coalescing drain traps) is essential because even trace oil + water forms an acidic sludge that corrodes internal piping and damages downstream equipment.
Piping Material and System Layout
Pharmaceutical compressed compressed-air distribution material selection depends on whether the line is in contact with the product or its packaging. For non-contact instrument and plant air, anodised aluminium piping is appropriate and commonly specified. For sterile direct-product-contact gases (for example WFI cover gas, sterile fill, aseptic blanket), 316L electropolished stainless steel with orbital welds is the GMP default because it can be steam-sterilised in-place and resists biofilm accumulation; aluminium is not suitable for these lines. Black iron piping is acceptable only for non-pharmaceutical facility air. Internal surface roughness must be minimised to prevent particle trapping and biofilm formation.
System layout must minimize pressure drop (typically designed for <0.5 bar drop across the distribution network) and include:
- Isolating block valve at compressor discharge
- Non-return (check) valve to prevent backflow during shut-down
- Pressure relief valve set 10% above operating pressure
- Pressure gauge and dew point monitoring point upstream of receiver
- Drain valve (with float trap or automatic solenoid) at receiver low point
- Secondary regulator and filter at each critical use point
Validation and In-Service Testing
TGA GMP requires documented validation at three stages:
Installation Qualification (IQ)
Verify that the installed system matches the design specification (compressor model, dryer type, filter stages, receiver size, piping material). Documentation must include equipment datasheets, P&ID (piping and instrumentation diagram), and calibration certificates for all instruments.
Operational Qualification (OQ)
Test the system under normal operating conditions and demonstrate that all parameters (pressure, dew point, flow, particle count) meet specification. OQ includes:
- Pressure stability test (run at full load for 2 to 4 hours; pressure must remain within ±0.2 bar of setpoint)
- Dew point measurement (using calibrated dew point meter; must be ≤specification)
- Particle count test (using laser particle counter to ISO 11171 standard; must not exceed ISO 8573-1:2010 class limits)
- Oil vapour test (using activated carbon absorption; must not exceed specification)
- Flow rate verification (confirm compressor output at stated pressure)
Performance Qualification (PQ)
Demonstrate sustained performance over time under actual production conditions. Performance Qualification (PQ) duration is not prescribed by PIC/S Annex 15. PIC/S Cl 3.14(i) requires tests under normal operating conditions with worst-case batch sizes; the frequency of sampling used to confirm process control should be justified. PIC/S Cl 3.13 places PQ after IQ and OQ. The PQ duration is a site-specific qualification deliverable, not a fixed calendar. Monitoring points include:
- Daily dew point and pressure checks
- Filter differential pressure trending (to detect clogging)
- Condensate drain inspection (colour and odour; should be water only, no oil)
- Sampling at point-of-use locations (near critical equipment) to confirm air quality at the actual application point
Maintenance, Monitoring and Change Control
Routine Maintenance Schedule
Intervals in the table below are indicative: replace filter elements when differential pressure reaches 0.3 bar or at the supplier-specified hour limit, whichever comes first. Dew-point drift outside specification, particle-count exceedance, or visible saturation of a cartridge overrides the scheduled interval. Record the trigger (hours, differential pressure, dew-point alarm, or QA finding) on the change-out log to satisfy GMP traceability.
| Task | Frequency | Rationale | Documentation |
|---|---|---|---|
| Visual inspection of system (leaks, noise, vibration) | Daily | Early detection of mechanical issues | Maintenance log |
| Receiver condensate drain | Daily | Remove accumulated water; prevent corrosion | Drain log (date, volume, appearance) |
| Pressure and dew point check | Daily | Verify system performance within specification | Monitoring sheet |
| Filter element visual inspection | Weekly | Check for saturation, bypass risk | Inspection log |
| Oil-water separator cartridge drain | Weekly or per indicator | Remove separated oil and water | Maintenance record |
| Dryer regeneration (desiccant only) | Per dryer design (typically every 8 to 24 hrs) | Restore desiccant capacity | Dryer run log |
| Compressor oil level and colour check (if applicable) | Monthly (oil-free: N/A) | Detect contamination or leakage | Log |
| Particulate filter element replacement | Every 500 to 1,000 operating hours or per pressure drop | Maintain ISO 8573-1:2010 class specification | Change-out log with element P/N and date |
| Fine filter element replacement | Every 500 to 1,000 operating hours or per pressure drop | Maintain particle purity | Change-out log |
| Desiccant dryer cartridge replacement (if desiccant used) | Every 1,000 to 2,000 operating hours or per dew point drift | Restore drying capacity; prevent moisture breakthrough | Log with cartridge type and installation date |
| Full system dew point and particle count validation | Annually or per change control | Confirm system meets specification; satisfy GMP requirement | Test report with lab accreditation |
| Pressure relief valve certification (external service) | Every 2 to 5 years per regulations | Ensure safety device function | Service certificate |
Monitoring Parameters and Alarm Thresholds
Pharmaceutical systems typically include:
- Pressure gauges: Analog or digital, set to alarm if pressure drops >0.5 bar below setpoint (indicative of compressor fault or major leak)
- Dew point continuous monitor: Early warning of dryer saturation or failure
- Filter pressure drop indicators: Alert when cartridge approaches end-of-life
- Condensate drain float trap: Automatic drain; overflow alarm if drain becomes blocked
Change Control and Re-Validation
Any modification to the system (new compressor, upgraded filter, dryer replacement, piping extension, etc.) requires a Change Control form detailing:
- Description of change and technical justification
- Impact assessment (does it affect validated air quality?)
- Re-validation scope (IQ/OQ/PQ or subset thereof)
- Approval by Quality Assurance before implementation
- Documentation of testing and results post-change
Most changes require at least OQ re-validation; major changes (new compressor) require full IQ/OQ/PQ.
Common Failures and Troubleshooting
| Failure Mode | Cause | Detection Method | Corrective Action |
|---|---|---|---|
| High dew point (moisture breakthrough) | Saturated desiccant dryer, faulty refrigerated dryer, or inadequate cooling | Daily dew point monitor; or wet spots inside piping | Replace dryer cartridge (desiccant) or service dryer (refrigerated); check aftercooler performance |
| Pressure drop below minimum | Compressor failure, major leak in piping, clogged intake filter | Pressure gauge; audible change in compressor sound | Check intake filter first (quick fix); isolate and inspect compressor; leak detection test on piping |
| Visible moisture or oil in receiver | Oil carryover from compressor (should not occur in oil-free unit; indicates seal failure), or inadequate drainage of condensate | Visual inspection during daily drain | For oil-free unit: service compressor seals; increase drain frequency; add secondary oil-water separator if dwell time allows; for condensate: ensure drain is operational and not blocked |
| Particle count exceeding specification | Clogged or degraded filter element, compressor internal wear (shedding particles), or leak in filter housing | Particle count test; filter pressure drop gauge | Replace filter element; inspect compressor for internal damage (may require rebuild); check filter housing seals for leaks |
| Compressor unload cycling (pressure rises and falls repeatedly) | Receiver too small, demand spike, dryer restriction, or clogged filter | Pressure gauge observation; compressor load/unload audible cycling | Verify demand is within design; check filter and dryer pressure drop; increase receiver size if demand profile has changed |
| Odour in discharged air (musty, chemical smell) | Microbial growth in receiver (biofilm) or decomposing oil residue | Olfactory during daily inspection; lab culture test (ISO 12500) | Flush receiver with hot water or approved cleaning agent; disinfect if necessary; increase drain frequency to prevent stagnant water |
Frequently Asked Questions
What ISO 8573-1 air quality class does TGA require for pharmaceutical compressed air?
TGA does not prescribe an ISO 8573-1 class directly. The class is set inside the site’s PIC/S PE009-17 GMP validation protocol against the actual product and process. In practice Australian pharmaceutical sites validate to Class 1.2.1 or tighter for parenteral, inhalation, and aseptic processing, Class 2 or 3 for general powder, tablet, and encapsulation operations, and Class 0 (specified stricter than Class 1) for inhalation products and parenteral container wash. The class must be defined in the validated design and tested against in IQ, OQ, and PQ.
Does the TGA mandate a specific compressed air standard?
No. The TGA enforces GMP under the Therapeutic Goods Act 1989 and aligns with the PIC/S PE009-17 guide (published 25 August 2023). Compressed air is named in TGA GMP guidance as a critical utility that must be validated, controlled, and monitored, but the specific ISO 8573-1 class, sample frequency, and acceptance limits are set by the site’s quality system against the product risk. The Annex 1 (2023 revision) contamination control requirements apply during normal operation and during maintenance.
What validation is required for a pharmaceutical compressed air system?
Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) are mandatory. Suppliers must provide documented evidence of design, testing, and performance against the validated air quality class. Any modification to the system, including a new compressor, filter upgrade, dryer change, or regulator adjustment, requires change control documentation and frequently re-validation. Records are retained for the life of the product batch plus the retention period, typically 25 years or more for pharmaceuticals.
Do I need an oil-free compressor for pharmaceutical manufacturing?
For direct-contact air in inhalation, parenteral, or aseptic processing, an oil-free compressor is the safest design because it removes the oil contamination pathway at the source. For indirect-support air on tablet operations, encapsulation, and packaging automation, an oil-injected compressor with multi-stage filtration and validated downstream monitoring can meet the required ISO 8573-1 class at lower capital cost. The decision is risk-based and must be supported by the validation file and the contamination control strategy under Annex 1.
How often must compressed air quality be tested in a TGA-licensed facility?
In-use parameters such as system pressure, dew point, and filter differential pressure are continuous or daily depending on the validated protocol. Full ISO 8573-1 air quality testing covering particles, water, oil, and microbiological load is typically annual at every validated use point, with quarterly testing for direct-contact air. Tests must be repeated after any compressor service, filter replacement, dryer change, or system modification. NATA-accredited laboratories should be used for results that auditors will accept.
What are the most common compressed air audit findings in Australian pharmaceutical facilities?
The recurring non-conformances are no documented ISO 8573-1 class in the validated design, overdue filter element replacement, missing or incomplete air quality test records (especially for particles and microbiological parameters), no corrective action procedure for failed tests, and undocumented equipment changes (compressor or filter stage modification without change control and re-validation). All are preventable through a structured compressed air management programme that ties the validated class to scheduled monitoring and to GMP change control.
Related Resources
- Air Compressors Australia: equipment types and selection guidance
- Oil-Free Compressors: design, benefits, and industrial applications
- Compressed Air Filtration: particle removal, coalescing filters, and activated carbon
- Compressed Air Dryers and Air Quality: dew point control, moisture management, and dryer selection
- Food Processing Industry: related GMP and FSANZ regulatory frameworks
- Medical and Dental Air Systems: AS 2896:2021 and AS 2568 requirements
- Compressed Air Piping and Distribution: materials, layout, and pressure drop
- Compressed Air Leak Detection: maintaining system integrity
- Energy Audit Guide: optimising compressed air energy consumption
- Compressed Air Systems Guide: system design fundamentals
- All Industry Solutions: explore compressed air applications across sectors
- TGA Pharmaceutical Compressed Air Compliance: regulatory requirements, ISO 8573-1 classes, and validation for TGA GMP manufacturing
- Leak Cost Calculator: estimate the annual electricity cost of compressed air leaks by size and pressure
- Dew point calculator: Size dryers to ISO 8573-1:2010 Class 2 water for pharmaceutical manufacturing
- Air Receiver Tanks for Pharmaceutical Compressed Air